©The Author(s) 2026.
World J Gastroenterol. Jan 14, 2026; 32(2): 111996
Published online Jan 14, 2026. doi: 10.3748/wjg.v32.i2.111996
Published online Jan 14, 2026. doi: 10.3748/wjg.v32.i2.111996
Table 4 Histopathological staging of immunoproliferative small intestinal disease
| Stage | Small intestine involvement | Lymph nodal involvement (mesenteric, other abdominal and retroperitoneal, etc.) |
| Stage A (benign) | Infiltration of the lamina propria, predominantly by mature lymphocytes and plasma cells, accompanied by variable degrees of villous atrophy | Mature plasmocytic infiltration, with limited disruption of the lymph node architecture |
| Stage B (intermediate) | Infiltration extending beyond the mucosa, spreading into the submucosa, characterized by atypical lymphoplasmacytic cells and immunoblastic-like cells, often associated with total or subtotal villous atrophy | Atypical plasmocytic and immunoblastic infiltration, leading to total or subtotal architectural disruption of the lymph nodes |
| Stage C (malignant) | Proliferation of histiocytes (Hodgkin sarcoma) affecting all layers of the intestinal wall. Large masses are formed and transformed into malignant lymphoma | Sarcomatous proliferation, extensively disrupting the entire lymph node architecture |
- Citation: Li MH, Wang QP, Ou CZ, Xu TM, Chen Y, Tang H, Zhang Y, Lai YJ, Qin XZ, Li J, Zhou WX, Li JN. Diagnostic clues in patients with clinical malabsorption and pathological small intestinal villous atrophy: Immune-mediated type and beyond. World J Gastroenterol 2026; 32(2): 111996
- URL: https://www.wjgnet.com/1007-9327/full/v32/i2/111996.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i2.111996